Billionaire Gary Michelson pledges $120M and backs Prop 38, an $8.4B California bond for immunology research; voters decide ...

A pooled analysis from the global SCORPIO clinical program showed potent antiviral activity with ensitrelvir across age, vaccination status and risk for severe disease New data underscores that even ...

The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.

Shanghai, China - October 16, 2026 - MicroPort Scientific Corporation announced that it and its associated companies have reached a cumulative total of 50 products accepted into China's National ...

New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in prostate ...

Ascentage Pharma Group International announced that lisaftoclax (APG-2575), the Company's novel Bcl-2 inhibitor, has been granted a Breakthrough Therapy Designation (BTD) by the Center for Drug ...

The 13-point charter also called for the restoration of GSCASH, the return of JNUEE and action on wider concerns over campus ...

An Indian clinical trial published in The Lancet found that an eight-week course of antiviral drugs cured nearly 99% of ...

Spread the love“`html Google’s recent strides in artificial intelligence, particularly in the medical field, have been nothing short of breathtaking. We’re talking about AI systems that can achieve ...

Detailed price information for Nuvectis Pharma Inc (NVCT-Q) from The Globe and Mail including charting and trades.

Three changes show what AI is already doing to everyday care. For someone with diabetes, an automated insulin delivery system ...

SeaStar Medical Holding Corp. ( ICU ), a commercial-stage healthcare company, said the U.S. FDA has granted Breakthrough Device Designation to its Selective Cytopheretic Device (SCD) therapy for ...